Israel Englander Regeneron Pharmaceuticals, Inc. Put Options Transaction History

Millennium Management LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$1024.09 - $1201.76 $33.5 Million - $39.3 Million	32,700 Added 28.86%	146,000 $153 Million
Q2 2024 Aug 14, 2024	SELL	$883.2 - $1071.19 $19.6 Million - $23.8 Million	-22,200 Reduced 16.38%	113,300 $119 Million
Q1 2024 May 15, 2024	SELL	$902.69 - $993.35 $44.7 Million - $49.2 Million	-49,500 Reduced 26.76%	135,500 $130 Million
Q4 2023 Feb 14, 2024	BUY	$775.18 - $881.7 $21.4 Million - $24.3 Million	27,600 Added 17.53%	185,000 $162 Million
Q2 2023 Aug 14, 2023	BUY	$700.03 - $830.35 $14.4 Million - $17 Million	20,500 Added 14.97%	157,400 $113 Million
Q1 2023 May 15, 2023	SELL	$680.49 - $826.97 $63.9 Million - $77.7 Million	-93,900 Reduced 40.68%	136,900 $112 Million
Q4 2022 Feb 14, 2023	BUY	$705.89 - $766.39 $17.4 Million - $18.9 Million	24,700 Added 11.98%	230,800 $167 Million
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $1.38 Million - $1.74 Million	2,400 Added 1.18%	206,100 $142 Million

1,535

83.8M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $79.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.